About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal.
The media mogul is being criticized by some for statements she made about thin people on the latest episode of her podcast.
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...